Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Mepolizumab (MPZ), an anti-interleukin-5 antibody, is effective for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). However, its effectiveness has not been adequately evaluated in real-world clinical practice. In this study, we assessed the effectiveness and safety...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Main Authors: Ueno, Masanobu, Miyagawa, Ippei, Nakano, Kazuhisa, Iwata, Shigeru, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Miyazaki, Yusuke, Kawabe, Akio, Yoshinari, Hiroko, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7962235/
https://ncbi.nlm.nih.gov/pubmed/33726827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02462-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares